Overview
Status
Active
Registry date
2023-03-24
Share capital
21 750,00 PLN
Registered address
ul. Milenijna 43/2, 03-130 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2023, 1 day late).
- 2025not filed
- 202415/07/2025
- 202316/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 49.46kMedianUSD 1.04mAverageUSD 6.01m
Net profit
This companyUSD -50.12kMedianUSD 18.57kAverageUSD 257.07k
Operating costs
This companyUSD 98.11kMedianUSD 988.13kAverageUSD 5.55m
Assets
This companyUSD 228.97kMedianUSD 762.77kAverageUSD 4.95m
Industry
Authorized Representatives
Krzysztof Jan Nazar – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Rafał Jaworowskiage 35 | 40 | $540.25 | 9.1954% |
Sebastian Kliszczage 35 | 30 | $405.19 | 6.8966% |
Stanisław Klocage 35 | 30 | $405.19 | 6.8966% |
| 105 | $1,418.15 | 24.1379% | |
Michał Trzaskowskiage 51 | 230 | $3,106.43 | 52.8736% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-05-12.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 27, 2023 | Aid for SME access to finance — aid for start-ups | $209.4K$209,419 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Curtis Evoplastsp. z o.o. | $17,862,367.20 | curtisdpt.pl | ||
| ICS Polandsp. z o.o. | $3,169,057.72 | ics-italy.it | ||
| Viva-Zipsp. z o.o. | $2,178,055.31 | vivazip.pl | ||
| PAC Polsp. z o.o. | $719,455.93 | pacpol.com.pl | ||
| 3DM Groupsp. z o.o. | $403,171.82 | 3dmgroup.pl | ||
| Sensetecsp. z o.o. | $251,672.30 | sensetec.pl | ||
| Hydrotekasp. z o.o. | $58,700.24 | hydroteka.pl | ||
| Termogumsp. z o.o. | $19,589.36 | termogum.pl | ||
| Wital L.B. Witczaksp. j. | – | wital.pl | ||
| Stempilsp. z o.o. | – | stempil.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-03-19 | Share capital change (6,600.00 PLN → 21,750.00 PLN) | |
| 2023-05-16 | Share capital change (5,000.00 PLN → 6,600.00 PLN) | |
| 2023-03-24 | Entered in the register |
FAQ
The main business activity of Acti Stent focuses on manufacture of other plastic products.
The company was registered in the Polish National Court Register (KRS) on March 24, 2023.
The headquarters is located at: ul. Milenijna 43, 03-130 Warszawa.
The share capital of the company is PLN 21,750 (approx. $5,875).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $49,456, representing an increase of 372.5% compared to 2023.
No, the company recorded a net loss of $50,116 in 2024.
The largest operating cost category falls under depreciation and amortization. This category amounted to $55,468 in 2024, representing 57% of all operating expenses.
Last updated: 2026-04-21
